正直发疯了。
Probity gone nuts.
出版信息
Nat Biotechnol. 2007 May;25(5):483. doi: 10.1038/nbt0507-483.
PMID:17483818
Abstract
The thinking behind the US Food and Drug Administration's (FDA) draft guidance on financial conflicts of interest for outside experts is deeply flawed.
摘要
美国食品药品监督管理局（FDA）针对外部专家财务利益冲突的指导草案背后的思路存在严重缺陷。
相似文献
1
Probity gone nuts.
Nat Biotechnol. 2007 May;25(5):483. doi: 10.1038/nbt0507-483.
2
Settling for second best?
Nat Biotechnol. 2007 Jul;25(7):715-6. doi: 10.1038/nbt0707-715.
3
Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
N Engl J Med. 2005 Jul 14;353(2):116-8. doi: 10.1056/NEJMp058108.
4
Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
MedGenMed. 2006 Oct 30;8(4):22.
5
Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
J Health Law. 2006 Fall;39(4):415-49.
6
Former FDA commissioner pleads guilty to two charges.
BMJ. 2006 Oct 28;333(7574):874. doi: 10.1136/bmj.333.7574.874-a.
7
8
Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings.
Mayo Clin Proc. 2017 Jul;92(7):1164-1166. doi: 10.1016/j.mayocp.2017.04.014.
9
US advisory panellists on drug's safety had ties to manufacturers.
BMJ. 2012 Jan 10;344:e244. doi: 10.1136/bmj.e244.
10
US proposes more stringent conflict-of-interest rules.
CMAJ. 2007 May 22;176(11):1571-2. doi: 10.1503/cmaj.070548.
Zotero 插件